FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |   Search Term  Advanced Search

Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe

Previous Volume 322:286-290 February 1, 1990 Number 5 Next

	Add to Personal Archive Add to Citation Manager Notify a Friend E-mail When Cited PubMed Citation

Abstract

Thiazide diuretic agents lower the urinary excretion of calcium. Their use has been associated with increased bone density, but their role in preventing hip fracture has not been established. We prospectively studied the effect of thiazide diuretic agents on the incidence of hip fracture among 9518 men and women 65 years of age or older residing in three communities. At base line, 24 to 30 percent of the subjects were thiazide users. In the subsequent four years, 242 subjects had hip fractures. The incidence rates of hip fracture were lower among thiazide users than nonusers in each community; the Mantel-Haenszel relative risk of hip fracture, adjusted for community and age, was 0.63 (95 percent confidence interval, 0.46 to 0.86). The protective effect of the use of thiazides was independent of sex, age, impaired mobility, body-mass index, and current and former smoking status; the multivariate adjusted relative risk of hip fracture was 0.68 (95 percent confidence interval, 0.49 to 0.94). Furthermore, the protective effect was specific to thiazide diuretic agents, since there was no association between the use of antihypertensive medications other than thiazides and the risk of hip fracture. These prospective data suggest that in older men and women the use of thiazide diuretic agents is associated with a reduction of approximately one third in the risk of hip fracture.

Source Information

Epidemiology, Demography, and Biometry Program, National Institute on Aging, Bethesda, Md.

This article has been cited by other articles:

• Khosla, S., Amin, S., Orwoll, E. (2008). Osteoporosis in Men. Endocr. Rev. 29: 441-464 [Abstract] [Full Text]  
• Miller, D. K., Wolinsky, F. D., Andresen, E. M., Malmstrom, T. K., Miller, J. P. (2008). Adverse Outcomes and Correlates of Change in the Short Physical Performance Battery Over 36 Months in the African American Health Project. Journals of Gerontology Series A: Biological Sciences and Medical Sciences 63: 487-494 [Abstract] [Full Text]  
• Dvorak, M. M., De Joussineau, C., Carter, D. H., Pisitkun, T., Knepper, M. A., Gamba, G., Kemp, P. J., Riccardi, D. (2007). Thiazide Diuretics Directly Induce Osteoblast Differentiation and Mineralized Nodule Formation by Interacting with a Sodium Chloride Co-Transporter in Bone. J. Am. Soc. Nephrol. 18: 2509-2516 [Abstract] [Full Text]  
• Felsenfeld, A. J., Levine, B. S. (2006). Milk Alkali Syndrome and the Dynamics of Calcium Homeostasis. CJASN 1: 641-654 [Full Text]  
• Geller, J. L., Adams, J. S. (2006). Statins and fracture: are all variables accounted for?. Arch Intern Med 166: 1041-1041 [Full Text]  
• Schlienger, R. G., Kraenzlin, M. E., Jick, S. S., Meier, C. R. (2004). Use of {beta}-Blockers and Risk of Fractures. JAMA 292: 1326-1332 [Abstract] [Full Text]  
• Schoofs, M. W.C.J., van der Klift, M., Hofman, A., de Laet, C. E.D.H., Herings, R. M.C., Stijnen, T., Pols, H. A.P., Stricker, B. H.Ch. (2003). Thiazide Diuretics and the Risk for Hip Fracture. ANN INTERN MED 139: 476-482 [Abstract] [Full Text]  
• Thomas, D. R. (2002). Guest Editorial: Focus on Functional Decline in Hospitalized Older Adults. Journals of Gerontology Series A: Biological Sciences and Medical Sciences 57: M567-568 [Full Text]  
• Mayan, H., Vered, I., Mouallem, M., Tzadok-Witkon, M., Pauzner, R., Farfel, Z. (2002). Pseudohypoaldosteronism Type II: Marked Sensitivity to Thiazides, Hypercalciuria, Normomagnesemia, and Low Bone Mineral Density. J. Clin. Endocrinol. Metab. 87: 3248-3254 [Abstract] [Full Text]  
• Wang, P. S., Bohn, R. L., Glynn, R. J., Mogun, H., Avorn, J. (2001). Hazardous Benzodiazepine Regimens in the Elderly: Effects of Half-Life, Dosage, and Duration on Risk of Hip Fracture. Am. J. Psychiatry 158: 892-898 [Abstract] [Full Text]  
• Bobrow, R. S., Cappuccio, F. P., Klibanski, A. (2001). Thiazide Use and Reduced Sodium Intake for Prevention of Osteoporosis. JAMA 285: 2323-2324 [Full Text]  
• Cruz, D. N. (2001). The renal tubular Na-Cl co-transporter (NCCT): a potential genetic link between blood pressure and bone density?. Nephrol Dial Transplant 16: 691-694 [Full Text]  
• LaCroix, A. Z., Ott, S. M., Ichikawa, L., Scholes, D., Barlow, W. E. (2000). Low-Dose Hydrochlorothiazide and Preservation of Bone Mineral Density in Older Adults: A Randomized, Double-Blind, Placebo-Controlled Trial. ANN INTERN MED 133: 516-526 [Abstract] [Full Text]  
• Wang, P. S., Solomon, D. H., Mogun, H., Avorn, J. (2000). HMG-CoA Reductase Inhibitors and the Risk of Hip Fractures in Elderly Patients. JAMA 283: 3211-3216 [Abstract] [Full Text]  
• Froom, J., Trilling, J. (2000). Reducing Antihypertensive Medication Use in Nursing Home Patients. Arch Fam Med 9: 378-383 [Abstract] [Full Text]  
• Heaney, R. P. (2000). Calcium, Dairy Products and Osteoporosis. J. Am. Coll. Nutr. 19: 83S-99 [Abstract] [Full Text]  
• Staessen, J. A., Roels, H., Fagard, R. (1996). Hypertension and Lead Exposure. JAMA 276: 1037-1038 [Abstract]  
• Ross, P. D. (1996). Osteoporosis: Frequency, Consequences, and Risk Factors. Arch Intern Med 156: 1399-1411 [Abstract]  
• Robinson, K., Mayer, E. L., Miller, D. P., Green, R., van Lente, F., Gupta, A., Kottke-Marchant, K., Savon, S. R., Selhub, J., Nissen, S. E., Kutner, M., Topol, E. J., Jacobsen, D. W. (1995). Hyperhomocysteinemia and Low Pyridoxal Phosphate : Common and Independent Reversible Risk Factors for Coronary Artery Disease. Circulation 92: 2825-2830 [Abstract] [Full Text]  
• Psaty, B. M., Koepsell, T. D., Yanez, N. D., Smith, N. L., Manolio, T. A., Heckbert, S. R., Borhani, N. O., Gardin, J. M., Gottdiener, J. S., Rutan, G. H., Siscovick, D. S., Furberg, C. D. (1995). Temporal Patterns of Antihypertensive Medication Use Among Older Adults, 1989 Through 1992: An Effect of the Major Clinical Trials on Clinical Practice?. JAMA 273: 1436-1438 [Abstract]  
• Avlund, K., Davidsen, M., Schultz-Larsen, K. (1995). Changes in Functional Ability from Ages 70 to 75: A Danish Longitudinal Study. J Aging Health 7: 254-282 [Abstract]  
• Heidrich, F. E., Stergachis, A., Gross, K. M. (1991). Diuretic Drug Use and the Risk for Hip Fracture. ANN INTERN MED 115: 1-6 [Abstract]  
• Ray, W. A. (1991). Thiazide Diuretics and Osteoporosis: Time for a Clinical Trial?. ANN INTERN MED 115: 64-65 [Abstract]  
• Larson, E. B. (1991). Geriatric Medicine. JAMA 265: 3125-3126 [Abstract]  
• Felson, D. T., Sloutskis, D., Anderson, J. J., Anthony, J. M., Kiel, D. P. (1991). Thiazide Diuretics and the Risk of Hip Fracture: Results From the Framingham Study. JAMA 265: 370-373 [Abstract]  
• Carasiti, M. E. (1990). Diuretics--Current Issues and Updates. Journal of Pharmacy Practice 3: 295-304